Skip to content

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing – Tech.eu

Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing – Tech.eu
Image: Tech.eu

Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne…

This is a summary

The full article is published by Tech.eu. We hold only a headline and a short summary here.

Read the full article